Original language | English (US) |
---|---|
Pages (from-to) | 31-32 |
Number of pages | 2 |
Journal | Journal of Allergy and Clinical Immunology |
Volume | 126 |
Issue number | 1 |
DOIs | |
State | Published - Jul 2010 |
Keywords
- Peanut allergy
- desensitization
- oral immunotherapy
ASJC Scopus subject areas
- Immunology and Allergy
- Immunology
Access to Document
Other files and links
Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS
In: Journal of Allergy and Clinical Immunology, Vol. 126, No. 1, 07.2010, p. 31-32.
Research output: Contribution to journal › Editorial › peer-review
}
TY - JOUR
T1 - Peanut oral immunotherapy is not ready for clinical use
AU - Thyagarajan, Ananth
AU - Varshney, Pooja
AU - Jones, Stacie M.
AU - Sicherer, Scott
AU - Wood, Robert
AU - Vickery, Brian P.
AU - Sampson, Hugh
AU - Burks, A. Wesley
N1 - Funding Information: Disclosure of potential conflict of interest: S. M. Jones has received research support from the National Peanut Board, the National Institutes of Health (NIAID), and DYAX Corp and is on the Medical Advisory Board for the Food Allergy and Anaphylaxis Network. S. Sicherer is a consultant for the Food Allergy Initiative and has received research support from the National Institutes of Health (NIAID), the Food Allergy and Anaphylaxis Network, and the Food Allergy Initiative . R. Wood has received research support from the National Institutes of Health and is on the Medical Advisory Board for the Food Allergy and Anaphylaxis Network. B. P. Vickery has received research support from the Thrasher Research Fund and the National Institutes of Health (NIAID). H. Sampson is a consultant for Allertein, LLC; has received research support from the Food Allergy Initiative and the National Institutes of Health (NIAID); is a consultant and scientific advisor for the Food Allergy Initiative; and is 45% owner of Herbal Springs, LLC. A. W. Burks is a consultant for ActoGeniX NV, Intelliject, McNeil Nutritionals, and Novartis; is a minority stockholder in Allertein and MastCell, Inc; is on the Advisory Board for Dannon Co Probiotics; is on the expert panel for Nutricia; has received research support from the National Institutes of Health, the Food Allergy and Anaphylaxis Network, and the Wallace Research Foundation ; has served as an expert witness on the topic of food allergy; is on the Medical Board of Directors for the Food Allergy and Anaphylaxis Network; is a Dermatological Allergy Committee Member for the American College of Allergy, Asthma, and Immunology; is a Study Section Member for the National Institutes of Health (HAI); and is on the Reviewer Board for the Journal of Allergy and Clinical Immunology and the US Food and Drug Administration. The rest of the authors have declared that they have no conflict of interest.
PY - 2010/7
Y1 - 2010/7
KW - Peanut allergy
KW - desensitization
KW - oral immunotherapy
UR - http://www.scopus.com/inward/record.url?scp=77954120475&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=77954120475&partnerID=8YFLogxK
U2 - 10.1016/j.jaci.2010.05.012
DO - 10.1016/j.jaci.2010.05.012
M3 - Editorial
C2 - 20620564
AN - SCOPUS:77954120475
SN - 0091-6749
VL - 126
SP - 31
EP - 32
JO - Journal of Allergy and Clinical Immunology
JF - Journal of Allergy and Clinical Immunology
IS - 1
ER -